SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Chemours Company, LLC – ‘10-12B’ on 12/18/14

On:  Thursday, 12/18/14, at 4:16pm ET   ·   Accession #:  1193125-14-446922   ·   File #:  1-36794

Previous ‘10-12B’:  None   ·   Next:  ‘10-12B/A’ on 2/12/15   ·   Latest:  ‘10-12B/A’ on 6/5/15   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/18/14  Chemours Company, LLC             10-12B                 2:2.1M                                   RR Donnelley/FA

Registration of Securities (General Form)   —   Form 10
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-12B      Registration of Securities (General Form)           HTML     27K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML   1.28M 


10-12B   —   Registration of Securities (General Form)


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  Form 10-12B  

As filed with the U.S. Securities and Exchange Commission on December 18, 2014

File No.                

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10

 

 

GENERAL FORM FOR REGISTRATION OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

The Chemours Company, LLC

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   46-4845564

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

1007 Market Street, Wilmington, Delaware   19898
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (302) 774-1000

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

 

Name of each exchange on which

each class is to be registered

Common Stock, par value $0.01 per share   New York Stock Exchange

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   x  (Do not check if a smaller reporting company)    Smaller reporting company   ¨

 

 

 


THE CHEMOURS COMPANY, LLC

INFORMATION REQUIRED IN REGISTRATION STATEMENT

CROSS-REFERENCE SHEET BETWEEN INFORMATION STATEMENT AND ITEMS OF FORM 10

Certain information required to be included in this Form 10 is incorporated by reference to specifically-identified portions of the body of the information statement filed herewith as Exhibit 99.1. None of the information contained in the information statement shall be incorporated by reference herein or deemed to be a part hereof unless such information is specifically incorporated by reference.

 

Item  1. Business.

The information required by this item is contained under the sections of the information statement entitled “Information Statement Summary,” “Cautionary Statement Concerning Forward-Looking Statements,” “Risk Factors,” “Management Discussion and Analysis of Financial Condition and Results of Operations,” “Business,” “The Distribution,” “Certain Relationships and Related Person Transactions,” “Our Relationship with DuPont Following the Distribution” and “Where You Can Find More Information.” Those sections are incorporated herein by reference.

 

Item  1A. Risk Factors.

The information required by this item is contained under the sections of the information statement entitled “Risk Factors” and “Cautionary Statement Concerning Forward-Looking Statements.” Those sections are incorporated herein by reference.

 

Item  2. Financial Information.

The information required by this item is contained under the sections of the information statement entitled “Selected Historical Condensed Combined Financial Data,” “Capitalization,” “Unaudited Pro Forma Condensed Combined Financial Statements” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Those sections are incorporated herein by reference.

 

Item  3. Properties.

The information required by this item is contained under the section of the information statement entitled “Business—Chemours Production Facilities and Technical Centers.” That section is incorporated herein by reference.

 

Item  4. Security Ownership of Certain Beneficial Owners and Management.

The information required by this item is contained under the section of the information statement entitled “Security Ownership of Certain Beneficial Owners and Management.” That section is incorporated herein by reference.

 

Item  5. Directors and Executive Officers.

The information required by this item is contained under the section of the information statement entitled “Management.” That section is incorporated herein by reference.

 

Item  6. Executive Compensation.

The information required by this item is contained under the sections of the information statement entitled “Compensation Discussion and Analysis” and “Executive Compensation.” Those sections are incorporated herein by reference.


Item  7. Certain Relationships and Related Transactions, and Director Independence.

The information required by this item is contained under the sections of the information statement entitled “Management,” “Executive Compensation,” “Certain Relationships and Related Person Transactions,” and “Our Relationship with DuPont Following the Distribution.” Those sections are incorporated herein by reference.

 

Item  8. Legal Proceedings.

The information required by this item is contained under the section of the information statement entitled “Business—Legal Proceedings.” That section is incorporated herein by reference.

 

Item  9. Market Price of, and Dividends on, the Registrant’s Common Equity and Related Stockholder Matters.

The information required by this item is contained under the sections of the information statement entitled “Risk Factors,” “Dividend Policy,” “Capitalization,” “The Distribution” and “Description of Our Capital Stock.” Those sections are incorporated herein by reference.

 

Item  10. Recent Sales of Unregistered Securities.

The information required by this item is contained under the section of the information statement entitled “Description of Our Capital Stock—Sale of Unregistered Securities.” That section is incorporated herein by reference.

 

Item  11. Description of Registrant’s Securities to be Registered.

The information required by this item is contained under the sections of the information statement entitled “Risk Factors,” “Dividend Policy,” “Capitalization,” “The Distribution” and “Description of Our Capital Stock.” Those sections are incorporated herein by reference.

 

Item  12. Indemnification of Directors and Officers.

The information required by this item is contained under the section of the information statement entitled “Description of Our Capital Stock—Limitations on Liability, Indemnification of Officers and Directors and Insurance.” That section is incorporated herein by reference.

 

Item  13. Financial Statements and Supplementary Data.

The information required by this item is contained under the sections of the information statement entitled “Index to Financial Statements” (and the financial statements referenced therein). That section is incorporated herein by reference.

 

Item  14. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

 

Item  15. Financial Statements and Exhibits.

 

(a) Financial Statements

The information required by this item is contained under the section of the information statement entitled “Index to Financial Statements” (and the financial statements referenced therein). That section is incorporated herein by reference.

 

(b) Exhibits

See below.


The following documents are filed as exhibits hereto:

 

Exhibit

Number

  

Exhibit Description

  2.1    Form of Separation Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company. *
  3.1    Form of Certificate of Incorporation of The Chemours Company. *
  3.2    Form of By-Laws of The Chemours Company. *
10.1    Form of Transition Services Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company. *
10.2    Form of Tax Matters Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company. *
10.3    Form of Employee Matters Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company. *
10.4    Form of Intellectual Property Cross-License Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company. *
21.1    Subsidiaries of The Chemours Company. *
99.1    Information Statement of The Chemours Company, preliminary and subject to completion, dated December 18, 2014.

 

* To be filed by amendment.


SIGNATURES

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  The Chemours Company, LLC
By:  

/s/ Nigel Pond

Name:   Nigel Pond
Title:   Vice President

Date: December 18, 2014


EXHIBIT INDEX

 

Exhibit

Number

  

Exhibit Description

  2.1    Form of Separation Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company. *
  3.1    Form of Certificate of Incorporation of The Chemours Company. *
  3.2    Form of By-Laws of The Chemours Company. *
10.1    Form of Transition Services Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company. *
10.2    Form of Tax Matters Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company. *
10.3    Form of Employee Matters Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company. *
10.4    Form of Intellectual Property Cross-License Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company. *
21.1    Subsidiaries of The Chemours Company. *
99.1    Information Statement of The Chemours Company, preliminary and subject to completion, dated December 18, 2014.

 

* To be filed by amendment.

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-12B’ Filing    Date    Other Filings
Filed on:12/18/14None on these Dates
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/27/15  SEC                               UPLOAD9/23/17    1:139K Chemours Co.
 5/05/15  SEC                               UPLOAD9/23/17    1:152K Chemours Co.
 2/26/15  SEC                               UPLOAD9/23/17    1:181K Chemours Co.
 1/15/15  SEC                               UPLOAD9/23/17    1:227K Chemours Co.
Top
Filing Submission 0001193125-14-446922   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 10:49:07.1am ET